4//SEC Filing
Noble James 4
Accession 0001104659-20-079787
CIK 0001621227other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 5:08 PM ET
Size
5.4 KB
Accession
0001104659-20-079787
Insider Transaction Report
Form 4
Noble James
DirectorChief Executive Officer
Transactions
- Award
Option to purchase Ordinary Shares
2020-07-01+179,785→ 179,785 totalExercise: $1.67From: 2021-07-01Exp: 2030-07-01→ Ordinary Shares (179,785 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP1.35 based on an exchange rate of $U.S. 1.2387 to GBP1.00. The actual exercise price will be the pounds sterling amount.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001388000
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 5:08 PM ET
- Size
- 5.4 KB